National Institutes of Health Pakistan (NIH)

What National Institutes of Health Pakistan (NIH) does

National Institutes of Health (NIH) Pakistan is a government autonomous public health institution established in 1965 as the National Health Center and granted autonomous status under Presidential Ordinance XLIII of 1980. Operating under the Ministry of National Health Services, Regulations and Coordination (MoNHSR&C), it serves as Pakistan's premier multi-disciplinary public health agency, delivering diagnostic services, vaccine and biological products manufacturing, food and drug quality control, research and development, and workforce training. The institution holds statutory designations as a WHO Collaborating Centre for Viral Diagnostics, Regional Reference Laboratory for Poliomyelitis, National Reference Center for Influenza Diagnosis, sole Federal Drug Appellate Laboratory, and Federal Narcotics Testing Laboratory, serving federal and provincial health departments, healthcare facilities, regulatory bodies, and the general public across Pakistan.

The institution operates 11 technical divisions and centers spanning disease surveillance (Centers for Disease Control, Field Epidemiology Training Program), reference laboratory services (Public Health Laboratories Division, National Health Laboratory), vaccine and biological manufacturing (Vaccine and Biological Products Center producing Typhoid-Cholera, Tetanus Toxoid, Measles, and Pak Vac COVID-19 vaccines; Sera Processing Laboratory producing Poly-valent Anti-Snake Venom Serum, Anti-Rabies Serum, and Anti-Tetanus Serum), and allied services including the Allergy Center, National Health Data Centre, Drug Control and Traditional Medicines Division, and the College of Medical Laboratory Technology. Core technical capabilities include metagenomic sequencing for wastewater environmental surveillance covering 33 nationally prioritized pathogens, DHIS-2-integrated disease surveillance across primary, secondary, and expanding tertiary healthcare facilities, AMR surveillance through the Pakistan Antimicrobial Resistance Surveillance System (PASS), cGMP-compliant biological manufacturing per WHO standards, ISO 9001:2015 quality certification, and 8 influenza sentinel sites across major cities. The institution has trained 390+ advanced field epidemiologists, 700+ frontline FETP fellows, and 2,500+ government officials through its training programs.

NIH's business model is government-funded, with core operations financed by MoNHSR&C budget allocations and project funding from international organizations including the Global Fund, Asian Development Bank, WHO, and CDC USA. Revenue streams include vaccine and biological product sales through government procurement, diagnostic and laboratory services to healthcare facilities, and grant-funded public health program implementation. The institution has no publicly disclosed pricing, with all transactions occurring through government procurement channels. Strategic partnerships include a February 2026 collaboration with Saudi Arabia for bilateral vaccine manufacturing self-sufficiency targeting 13 vaccine types, ongoing cooperation with WHO and CDC USA on disease surveillance training, and One Health partnerships with the National Agriculture Research Center for zoonotic disease surveillance.

Name

National Institutes of Health Pakistan (NIH)

Legal name

National Institutes of Health, Islamabad Pakistan

Website

https://nih.org.pk

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

251–500 employees

Short description

National Institutes of Health Pakistan is a government autonomous public health institution under the Ministry of National Health Services, providing diagnostic services, vaccine and biological product manufacturing, disease surveillance, regulatory laboratory testing, and workforce training to federal and provincial health departments across Pakistan.

Ownership category

akta.pro rank

Product category

Government Public Health Services

NAICS

Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413), Administration of Public Health Programs (92312)

SIC

Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAJAIAA

National Public Health Reference Laboratories

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

SECONDARYHLAJAHAA

National/State/Local Immunization Program Offices

Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration

SECONDARYHLAJAIAD

Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza)

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

SECONDARYBPAIAJAF

Public Health Laboratories & Diagnostic Oversight

Business & Public Services/Public Sector & Government Administration/Public Health Administration & Regulation

SECONDARYHLAKAAAL

Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT)

Healthcare & Life Sciences/Specialist Medical Practice/Allergy & Immunology

SECONDARYHLAIAEAM

Vaccine Clinical Development & Regulatory Affairs

Healthcare & Life Sciences/Pharmaceuticals/Vaccines

Keywords

• Public health services
• Vaccine manufacturing
• Laboratory diagnostics
• Disease surveillance
• Biological products

Headquarters

HQ city

Islamabad

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Vaccine and Biological Products: Production and sale of vaccines including typhoid-cholera, tetanus toxoid, measles vaccines, and biological products including anti-snake venom serum and anti-rabies serum. Revenue generated through government procurement and public health programs.
2. Diagnostic and Laboratory Services: Comprehensive laboratory testing services for government and private healthcare facilities, including reference laboratory services, quality control testing, and specialized diagnostic tests.
3. Government Funding and Grants: Core operational funding from Ministry of National Health Services Regulations and Coordination, with additional project funding from international organizations including Global Fund, ADB, and WHO.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

National Institutes of Health Pakistan is a government autonomous public health institution providing multi-disciplinary services including diagnostic laboratory testing for communicable diseases, manufacturing of vaccines and biological products (typhoid-cholera vaccine, tetanus toxoid, anti-snake venom serum, anti-rabies serum), disease surveillance and outbreak response, food and drug quality control testing, field epidemiology training, and allergy diagnosis and immunotherapy. It serves as WHO Collaborating Centre for Viral Diagnostics and Regional Reference Laboratory for Poliomyelitis.

Product overview

National Institutes of Health Pakistan (NIH) operates as a multi-disciplinary public health institution offering a comprehensive portfolio of products and services. The core offerings include: (1) Vaccine Products — Typhoid-Cholera combined vaccine and Tetanus Toxoid vaccine; (2) Anti-Sera Products — Poly-valent Anti-Snake Venom Serum, Anti-Rabies Serum, and Anti-Tetanus Serum manufactured at cGMP-compliant facilities; (3) Diagnostic and Laboratory Services — Public Health Laboratories Division providing reference testing for viral diagnostics, polio, influenza, and other communicable diseases; (4) Healthcare Services — Allergy Center for diagnosis and immunotherapy treatment; (5) Data and Surveillance Services — National Health Data Centre serving as central health data repository, Disease Surveillance systems (IDSR, PASS, MSS), and Wastewater Environmental Surveillance; (6) Training Programs — Field Epidemiology Training Program (FETP) and College of Medical Laboratory Technology (CMLT); (7) Research and Knowledge Services — Scientific publications and Central Library with digital resources.

Differentiator

Problem solved

Functional benefit

Products and services

• Typhoid-Cholera Vaccine Combined bacterial vaccine for immunization against typhoid and cholera diseases, produced by NIH for use in public immunization programs.
• Tetanus Toxoid Vaccine Vaccine for prevention of tetanus infection, part of routine immunization programs in Pakistan.
• Poly-valent Anti-Snake Venom Serum (Poly-ASVS) Antivenom serum against medically important venomous snake species (Cobras, Russell Viper, Kraits, Echis). Sole manufacturer in Pakistan since 1967, manufactured at cGMP-compliant facility.
• Anti-Rabies Serum (ARS) Equine-origin antiserum for rabies post-exposure prophylaxis manufactured by NIH.
• Anti-Tetanus Serum Serum product for tetanus prevention and treatment manufactured by NIH.
• Public Health Laboratories Division (PHLD) Diagnostic Services WHO Collaborating Centre providing reference diagnostic facilities for communicable diseases including Dengue, Avian Influenza, Congo, SARS, Hepatitis, HIV/AIDS, Polio, and Measles.
• Allergy Center Diagnosis and Treatment Sole public sector institution providing allergy diagnosis, skin prick tests, and immunotherapy/vaccination treatment for allergic conditions, serving 800+ daily patients.
• National Health Data Centre (NHDC) Central repository for national health data, providing data analytics, database maintenance, and interactive dashboards for disease surveillance and policy decision-making.
• Field Epidemiology Training Program (FETP) Two-year advanced and three-month frontline training programs for government health workers in field epidemiology, with 390+ advanced epidemiologists and 700+ frontline fellows graduated.
• National Stop Transmission of Polio (NSTOP) Program deploying FETP-trained epidemiologists as N-STOP officers in high-risk districts for polio eradication support across Pakistan.
• Pakistan Mortality Surveillance System (MSS) National mortality surveillance system for tracking and analyzing death data across Pakistan to inform public health policy.
• Wastewater Environmental Surveillance (WES) Program National program for detection and monitoring of 33 prioritized pathogens in wastewater using metagenomic sequencing for early warning of infectious disease outbreaks.
• Pakistan Antimicrobial Resistance Surveillance System (PASS) National antimicrobial resistance surveillance system implemented by NIH in coordination with WHO GLASS for monitoring AMR trends across Pakistan.
• Federal Drug Appellate Laboratory Services Federal appellate laboratory services for pharmaceutical quality control testing and narcotics testing serving Drug Courts, Provincial Quality Control Boards, and DRAP.
• Central Library Services Specialized biomedical library services providing access to HEC Digital Library resources including ProQuest, ASTM, SpringerLink, Taylor & Francis, Wiley, and Ovid with 11,003 books and WHO technical reports.

Quantifiable outcome

• Pakistan ranked as the 3rd best country globally in effectively handling and managing the COVID-19 pandemic
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Six partnerships are on record, tiered major, core and supporting.

• Kingdom of Saudi Arabia (KSA)majorStrategic or Co-development Partner · 1 February 2026High-level Saudi delegation led by Senior Advisor to Minister of Industry visited NIH Pakistan in February 2026 to explore vaccine manufacturing collaboration. Discussions focused on local vaccine production for 13 diseases, with Saudi Arabia providing technical and investment support. Goal is bilateral self-sufficiency in vaccine production, with NIH serving as primary local manufacturing partner. Population of approximately 240 million requires 6.2 million vaccine doses annually for children.
• Global Health Security Agenda (GHSA)coreStrategic or Co-development Partner · 1 January 2015Pakistan has been a member of GHSA since 2015 and selected as Steering Group member in 2020. GHSA platform facilitates multi-sector collaboration for accelerating progress toward health security through workforce development, laboratory system strengthening, and enhancing capacities to prevent, detect, and respond to infectious disease threats.
• Centers for Disease Control and Prevention (CDC), USAcoreStrategic or Co-development Partner · 1 January 2007Collaborative partner in Field Epidemiology Training Program (FETP), established in 2007 as joint initiative of NIH, Ministry of NHSR&C, and CDC USA. CDC provides technical assistance for lab-based surveillance programs on Human-Avian-Swine Influenza and Bacterial Meningitis. Program aims to strengthen IHR core capacity and real-time surveillance capabilities.
• World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 1980NIH Pakistan serves as WHO Collaborating Centre for Research and Training in Viral Diagnostics since the 1980s. Also designated as Regional Reference Laboratory for Poliomyelitis and National Reference Center for Influenza diagnosis. Provides influenza strains annually for WHO vaccine composition recommendations and participates in WHO global disease surveillance networks including GLASS for antimicrobial resistance surveillance.
• National Agriculture Research Center (NARC)supportingStrategic or Co-development PartnerCooperative agreement established to strengthen zoonotic disease surveillance system and enhance collaboration between human and animal health sectors under the One Health approach. Ten veterinarians currently enrolled in FELTP program.
• Pakistan Army Medical ServicessupportingStrategic or Co-development PartnerPakistan Army doctors participate in the 2-year FELTP program since 2014. Army Medical College serves as venue for NIH recruitment tests. Military veterinary services support Sera Processing Laboratory operations.

Scale indicators20 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Oswaldo Cruz Foundation (Fiocruz): Brazil's leading public health institution combining reference laboratories, vaccine and biological product manufacturing, public health research, and training. Closest structural comparable to NIH Pakistan due to its integrated biologics production plus reference lab plus research model in an emerging market context.
• Indian Council of Medical Research (ICMR): India's apex body for biomedical research and reference laboratory network, with parallel national institute structure, vaccine R&D, and disease surveillance functions. Most direct comparable as a national-level public health institution in a neighboring South Asian country with similar demographic and epidemiological profile.
• Nigeria Centre for Disease Control (NCDC): Nigeria's national public health agency established in 2011 with reference laboratory network, surveillance, and emergency response functions. Comparable as an emerging-market national public health institution with similar donor dependency, FETP-style training programs, and disease surveillance mandate.
• National Institute for Communicable Diseases (NICD), South Africa: South Africa's national public health reference laboratory with disease surveillance, virology reference functions, and WHO collaborating centre status. Comparable as a WHO-designated regional reference lab operating in an emerging market public health system.
• National Institute of Virology (NIV), India: India's premier virology reference laboratory under ICMR, designated WHO Collaborating Centre and H5N1 reference lab. Most direct operational comparable to NIH Pakistan's Public Health Laboratories Division in terms of viral diagnostics, regional reference status, and LMIC public health virology focus.
• Institut Pasteur: Global reference for viral diagnostics with WHO Collaborating Centre status, vaccine production, and research mandate. NIH Pakistan's Public Health Laboratories Division mirrors Pasteur's structure as a viral diagnostics reference centre with regional WHO designation.

Regional players

• Korea Disease Control and Prevention Agency (KDCA): South Korea's national CDC with integrated disease surveillance, reference laboratory functions, and public health emergency response authority. Comparable organizational structure though operating in a higher-income country context with stronger commercial biotech ecosystem.

Broad incumbents

• Robert Koch Institute (RKI): Germany's federal public health institute responsible for disease surveillance, reference laboratory functions, and infectious disease control. Comparable as a government public health reference body with statutory authority over laboratory standards and epidemiological reporting.
• Centers for Disease Control and Prevention (US CDC): The global benchmark for national public health agencies, operating reference labs, vaccine production partnerships, and FETP-style training programs. NIH Pakistan is a formal CDC partner on FETP since 2007, mirroring a scaled-down version of CDC's structure with disease control, laboratory, and training divisions.
• Chinese Center for Disease Control and Prevention (China CDC): China's national public health agency with reference laboratory functions, vaccine policy authority, and integrated disease surveillance. Comparable in scope as a national-level multi-disciplinary public health institution with regulatory authority over biologics and disease control.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/NIH_Pakistan
• Facebookfacebook.com/NIH.PK
• LinkedInlinkedin.com/company/national-institute-of-health

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Institutes of Health Pakistan (NIH)